Quest Diagnostics Inc
DGX173.700USD
+0.170+0.10%
Close 01/02, 16:00（ET）Quotes delayed by 15 min
19.28BMarket Cap
20.16P/E TTM
More Details of Quest Diagnostics Inc Company
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
Quest Diagnostics Inc Info
Ticker SymbolDGX
Company nameQuest Diagnostics Inc
IPO dateDec 17, 1996
CEODavis (James E)
Number of employees45000
Security typeOrdinary Share
Fiscal year-endDec 17
Address500 Plaza Drive
CitySECAUCUS
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code07094
Phone19735202700
Websitehttps://www.questdiagnostics.com/
Ticker SymbolDGX
IPO dateDec 17, 1996
CEODavis (James E)
Company Executives of Quest Diagnostics Inc
Name
Name/Position
Position
Shareholding
Change
Ms. Catherine T. (Cathy) Doherty
Ms. Catherine T. (Cathy) Doherty
Executive Vice President - Regional Businesses
Executive Vice President - Regional Businesses
72.49K
-1.40%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Lead Independent Director
Lead Independent Director
45.61K
+2.71%
Mr. Michael E. Prevoznik
Mr. Michael E. Prevoznik
Senior Vice President, General Counsel
Senior Vice President, General Counsel
39.12K
--
Mr. Gary M. Pfeiffer
Mr. Gary M. Pfeiffer
Independent Director
Independent Director
33.40K
-4.25%
Mr. Timothy L. (Tim) Main
Mr. Timothy L. (Tim) Main
Independent Director
Independent Director
26.30K
+4.79%
Ms. Vicky B. Gregg
Ms. Vicky B. Gregg
Independent Director
Independent Director
17.04K
-6.84%
Ms. Denise M. Morrison
Ms. Denise M. Morrison
Independent Director
Independent Director
11.85K
+11.30%
Mr. Karthik Kuppusamy
Mr. Karthik Kuppusamy
Senior Vice President - Clinical Solutions
Senior Vice President - Clinical Solutions
10.25K
+0.15%
Ms. Tracey C. Doi
Ms. Tracey C. Doi
Independent Director
Independent Director
6.46K
+22.86%
Mr. Robert B. (Rob) Carter
Mr. Robert B. (Rob) Carter
Independent Director
Independent Director
2.70K
+0.22%
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Catherine T. (Cathy) Doherty
Ms. Catherine T. (Cathy) Doherty
Executive Vice President - Regional Businesses
Executive Vice President - Regional Businesses
72.49K
-1.40%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Lead Independent Director
Lead Independent Director
45.61K
+2.71%
Mr. Michael E. Prevoznik
Mr. Michael E. Prevoznik
Senior Vice President, General Counsel
Senior Vice President, General Counsel
39.12K
--
Mr. Gary M. Pfeiffer
Mr. Gary M. Pfeiffer
Independent Director
Independent Director
33.40K
-4.25%
Mr. Timothy L. (Tim) Main
Mr. Timothy L. (Tim) Main
Independent Director
Independent Director
26.30K
+4.79%
Ms. Vicky B. Gregg
Ms. Vicky B. Gregg
Independent Director
Independent Director
17.04K
-6.84%
Revenue Breakdown
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
0.00
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
12.77%
T. Rowe Price Associates, Inc.
6.15%
BlackRock Institutional Trust Company, N.A.
5.51%
State Street Investment Management (US)
4.70%
Boston Partners
3.63%
Other
67.25%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
12.77%
T. Rowe Price Associates, Inc.
6.15%
BlackRock Institutional Trust Company, N.A.
5.51%
State Street Investment Management (US)
4.70%
Boston Partners
3.63%
Other
67.25%
Shareholder Types
Shareholders
Proportion
Investment Advisor
55.48%
Investment Advisor/Hedge Fund
32.65%
Research Firm
4.36%
Pension Fund
2.24%
Bank and Trust
1.67%
Hedge Fund
1.52%
Sovereign Wealth Fund
1.23%
Individual Investor
0.44%
Insurance Company
0.11%
Other
0.30%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
1802
110.45M
99.29%
-4.04M
2025Q3
1807
110.10M
100.22%
-700.93K
2025Q2
1819
110.85M
98.75%
+3.78M
2025Q1
1805
107.66M
97.04%
-1.03M
2024Q4
1782
103.84M
96.80%
+1.47M
2024Q3
1731
102.61M
95.91%
+134.75K
2024Q2
1739
102.41M
97.25%
-2.03M
2024Q1
1743
104.12M
95.50%
-1.89M
2023Q4
1768
101.63M
97.47%
-890.08K
2023Q3
1758
103.19M
98.04%
-229.61K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
14.20M
12.77%
+16.93K
+0.12%
Sep 30, 2025
T. Rowe Price Associates, Inc.
6.84M
6.15%
-192.73K
-2.74%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
6.13M
5.51%
-81.33K
-1.31%
Sep 30, 2025
State Street Investment Management (US)
5.22M
4.7%
+38.93K
+0.75%
Sep 30, 2025
Boston Partners
4.04M
3.63%
+997.03K
+32.80%
Sep 30, 2025
JP Morgan Asset Management
3.77M
3.39%
+8.99K
+0.24%
Sep 30, 2025
Geode Capital Management, L.L.C.
3.04M
2.73%
+54.07K
+1.81%
Sep 30, 2025
Victory Capital Management Inc.
2.34M
2.11%
-465.25K
-16.56%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.91M
1.71%
+6.16K
+0.32%
Sep 30, 2025
Wells Fargo Advisors
1.76M
1.59%
-30.59K
-1.70%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares U.S. Healthcare Providers ETF
3.1%
Madison Dividend Value ETF
2.17%
State Street SPDR S&P Health Care Services ETF
1.99%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
1.81%
First Trust Total US Market AlphaDEX ETF
1.8%
Invesco S&P 500 Equal Weight Health Care ETF
1.59%
Acruence Active Hedge US Equity ETF
1.26%
First Trust Health Care Alphadex Fund
1.21%
Timothy Plan High Dividend Stock ETF
1.19%
VictoryShares US Value Momentum ETF
1.01%
View more
iShares U.S. Healthcare Providers ETF
Proportion3.1%
Madison Dividend Value ETF
Proportion2.17%
State Street SPDR S&P Health Care Services ETF
Proportion1.99%
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
Proportion1.81%
First Trust Total US Market AlphaDEX ETF
Proportion1.8%
Invesco S&P 500 Equal Weight Health Care ETF
Proportion1.59%
Acruence Active Hedge US Equity ETF
Proportion1.26%
First Trust Health Care Alphadex Fund
Proportion1.21%
Timothy Plan High Dividend Stock ETF
Proportion1.19%
VictoryShares US Value Momentum ETF
Proportion1.01%
Dividend
A total of
1.26B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Nov 11, 2025
DGX.NB Interim Cash Dividend of gross USD 0.8 paid on Jan 28, 2026 going ex on Jan 13, 2026
Jan 13, 2026
Jan 28, 2026
Jan 13, 2026
Aug 13, 2025
DGX.NB Final Cash Dividend of gross USD 0.8 paid on Oct 20, 2025 going ex on Oct 03, 2025
Oct 03, 2025
Oct 20, 2025
Oct 03, 2025
May 14, 2025
DGX.NB Interim Cash Dividend of gross USD 0.8 paid on Jul 21, 2025 going ex on Jul 07, 2025
Jul 07, 2025
Jul 21, 2025
Jul 07, 2025
Jan 30, 2025
DGX.NB Interim Cash Dividend of gross USD 0.8 paid on Apr 21, 2025 going ex on Apr 07, 2025
Apr 07, 2025
Apr 21, 2025
Apr 07, 2025
Nov 12, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Jan 29, 2025 going ex on Jan 14, 2025
Jan 14, 2025
Jan 29, 2025
Jan 14, 2025
Aug 14, 2024
DGX.NB Final Cash Dividend of gross USD 0.75 paid on Oct 21, 2024 going ex on Oct 04, 2024
Oct 04, 2024
Oct 21, 2024
Oct 04, 2024
May 15, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Jul 22, 2024 going ex on Jul 08, 2024
Jul 08, 2024
Jul 22, 2024
Jul 08, 2024
Feb 01, 2024
DGX.NB Interim Cash Dividend of gross USD 0.75 paid on Apr 22, 2024 going ex on Apr 05, 2024
Apr 08, 2024
Apr 22, 2024
Apr 05, 2024
Nov 14, 2023
DGX.NB Interim Cash Dividend of gross USD 0.71 paid on Jan 31, 2024 going ex on Jan 16, 2024
Jan 17, 2024
Jan 31, 2024
Jan 16, 2024
Aug 14, 2023
DGX.NB Final Cash Dividend of gross USD 0.71 paid on Oct 23, 2023 going ex on Oct 05, 2023 with reinvestment option
Oct 06, 2023
Oct 23, 2023
Oct 05, 2023
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Quest Diagnostics Inc?
The top five shareholders of Quest Diagnostics Inc are:
The Vanguard Group, Inc. holds 14.20M shares, accounting for 12.77% of the total shares.
T. Rowe Price Associates, Inc. holds 6.84M shares, accounting for 6.15% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 6.13M shares, accounting for 5.51% of the total shares.
State Street Investment Management (US) holds 5.22M shares, accounting for 4.70% of the total shares.
Boston Partners holds 4.04M shares, accounting for 3.63% of the total shares.
The Vanguard Group, Inc. holds 14.20M shares, accounting for 12.77% of the total shares.
T. Rowe Price Associates, Inc. holds 6.84M shares, accounting for 6.15% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 6.13M shares, accounting for 5.51% of the total shares.
State Street Investment Management (US) holds 5.22M shares, accounting for 4.70% of the total shares.
Boston Partners holds 4.04M shares, accounting for 3.63% of the total shares.
What are the top three shareholder types of Quest Diagnostics Inc?
The top three shareholder types of Quest Diagnostics Inc are:
The Vanguard Group, Inc.
T. Rowe Price Associates, Inc.
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
T. Rowe Price Associates, Inc.
BlackRock Institutional Trust Company, N.A.
How many institutions hold shares of Quest Diagnostics Inc (DGX)?
As of 2025Q4, 1802 institutions hold shares of Quest Diagnostics Inc, with a combined market value of approximately 110.45M, accounting for 99.29% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.93%.
What is the biggest source of revenue for Quest Diagnostics Inc?
In FY2025Q3, the -- business generated the highest revenue for Quest Diagnostics Inc, amounting to -- and accounting for --% of total revenue.
